Regulations.gov document
Reference 9 Federal Register, August 24, 2007 (72 FR 48765), Current Good Manufacturing…
Supporting & Related Material · FDA-2005-D-0140 · posted Dec 28, 2017
Key facts
| Document ID | FDA-2005-D-0140-0020 |
|---|---|
| Title | Reference 9 Federal Register, August 24, 2007 (72 FR 48765), Current Good Manufacturing Practice for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting Hepatitis C Virus Infection (“Lookback”); Final Rule. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2005-D-0140 |
| Posted | Dec 28, 2017 |
At a glance
- None Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: